BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment (BIOSAMOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03361111
Recruitment Status : Recruiting
First Posted : December 4, 2017
Last Update Posted : October 5, 2018
Information provided by (Responsible Party):
Joanna Hermanowicz-Salamon, Medical University of Warsaw

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 5, 2018
  Estimated Study Completion Date : December 30, 2018
Publications of Results: